Top 13 amrytpharma.com competitors & alternatives
[Amryt Pharma Plc - Hope for those with the greatest need We are a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments that help improve the lives of people with rare and orphan diseases.]
amrytpharma.com competitors and alternatives
Top 13 amrytpharma.com competitors and alternatives are ranked by similar search terms, traffic and worth.
amrytpharma.com's top 5 competitors are: ebresearch.org with 100 daily traffic and 236,100 estimated worth, horizontherapeutics.com with 390 daily traffic and 88,800 estimated worth, cure-eb.org with 0 daily traffic and 16,700 estimated worth, 4dpharmaplc.com with 150 daily traffic and 14,800 estimated worth, shardcapital.com with 0 daily traffic and 3,400 estimated worth.
ebresearch.org
EB Research Partnership - EB Research Partnership
EB Research Partnership is the largest 501(c)(3) nonprofit dedicated to funding research aimed at treating and ultimately curing Epidermolysis Bullosa, a group of devastating and life-threatening skin disorders that affect children from birth.
Daily Traffic: 100
Website Worth: $ 236,100
horizontherapeutics.com
Horizon Therapeutics
We're Horizon, a global biotechnology company driven by a simple idea: we believe that science and compassion must work together to transform lives.
Daily Traffic: 390
Website Worth: $ 88,800
cure-eb.org
Cure EB - Accelerating research to end painful skin - Recessive Dystrophic Epidermolysis Bullosa
Accelerating research to end painful skin #MARATHONAMONTH CHALLENGE 'I am running marathons around Regents Park for Cure EB because I hate running but I hate EB more, we need a cure' Text: 'Cure 3' 'Cure 5' 'Cure 10'to 70300 to give £3, £5, £10 Cure EB Acc ...
Daily Traffic: 0
Website Worth: $ 16,700
4dpharmaplc.com
4D Pharma plc - developing science, delivering therapies
We understand that the bacteria of the gut microbiome have an important function in health and disease, but importantly – we understand how they function, and how they could be used as potential new therapies.
Daily Traffic: 150
Website Worth: $ 14,800
shardcapital.com
Shard Capital
Shard Capital is a leading wealth and asset manager. We offer investment, dealing, capital markets services to private, corporate and institutional clients.
Daily Traffic: 0
Website Worth: $ 3,400
eb-haus.org
EB-Haus Austria
Das EB-Haus Austria ist ein Expertisezentrum für Epidermolysis bullosa und zugleich Spezialklinik für „Schmetterlingskinder“.
Daily Traffic: 0
Website Worth: $ 0
veronapharma.com
Verona Pharma | Innovative Respiratory Treatments
Verona Pharma develops novel treatments like ensifentrine in COPD. Future development is focused on chronic lung diseases such as COPD, asthma, and cystic fibrosis. Explore our advancements, patient insights, and latest investor news
Daily Traffic: 0
Website Worth: $ 0
juxtapid.com
Home | Juxtapid® (lomitapide) capsules | Patient
juxtapid is a prescription medicine that helps to lower cholesterol levels for people with homozygous familial hypercholesterolemia (hofh).
Daily Traffic: 0
Website Worth: $ 0
destinypharma.com
Destiny Pharma
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. The Company is developing novel antimicrobial drugs from its “in-house” XF platform and also from recently acquired Biotherapeutic products that harness beneficial components of the human microbiome. We have two exciting late stage clinical […]
Daily Traffic: 0
Website Worth: $ 0
debra.org.nz
Home | Debra NZ | Official Website
Welcome to DEBRA. We aim to improve the quality of life for people with Epidermolysis Bullosa (EB) and their familes.
Daily Traffic: 0
Website Worth: $ 0
Share on Social Media
Similar sites like amrytpharma.com